| Ticker Details |
Surmodics, Inc.
Surmodics Inc is a provider of surface modification and in vitro diagnostic technologies to the healthcare industry.
|
| IPO Date: |
March 4, 1998 |
| Sector: |
Healthcare |
| Industry: |
Health Care Equipment and Supplies |
| Market Cap: |
$614.51M |
| Activated in VL: |
False |
| Average Daily Range |
| Avg Daily Range: |
$0.50 | 1.60%
|
| Avg Daily Range (30 D): |
$0.32 | 1.05%
|
| Avg Daily Range (90 D): |
$0.39 | 1.20%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.1M |
| Avg Daily Volume (30 D): |
.61M |
| Avg Daily Volume (90 D): |
.31M |
| Trade Size |
| Avg Trade Size (Sh.): |
120 |
| Avg Trade Size (Sh.) (30 D): |
229 |
| Avg Trade Size (Sh.) (90 D): |
124 |
| Institutional Trades |
| Total Institutional Trades: |
1,853 |
| Avg Institutional Trade: |
$1.73M |
| Avg Institutional Trade (30 D): |
$2.15M |
| Avg Institutional Trade (90 D): |
$1.89M |
| Avg Institutional Trade Volume: |
.05M |
| Avg Institutional Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$1.29M |
| Avg Closing Trade (30 D): |
$1.56M |
| Avg Closing Trade (90 D): |
$1.02M |
| Avg Closing Volume: |
36.5K |
|
|
| Financials |
| |
TTM |
Q3 2025 |
Q2 2025 |
|
Basic EPS
|
|
$-.37
|
$-.36
|
|
Diluted EPS
|
|
$-.37
|
$-.36
|
|
Revenue
|
|
$29.57M
|
$28.09M
|
|
Gross Profit
|
|
$20.99M
|
$20.26M
|
|
Net Income / Loss
|
|
$-5.32M
|
$-5.21M
|
|
Operating Income / Loss
|
|
$-5.24M
|
$-4.01M
|
|
Cost of Revenue
|
|
$8.58M
|
$7.83M
|
|
Net Cash Flow
|
|
$-3.56M
|
$-1.28M
|
|
PE Ratio
|
|
|
|
|
|
|